Whatever the case might be, once we get approved,
Post# of 148190
Quote:Agreed.
Whatever the case might be, once we get approved, with 600000 doses (1.2M vials) we should have a revenue of app. $1.4 Billion ($1153 per shot). In 2021 this figure should be much higher as we ramp up sales.
However, we do need to factor payments to AbbVie, Lantheus Holdings (Progenics), and of course American Regent.